Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1
- PMID: 6407998
- PMCID: PMC264768
- DOI: 10.1128/iai.41.1.232-236.1983
Characterization of the antibody response in inbred mice to a high-molecular-weight polysaccharide from Pseudomonas aeruginosa immunotype 1
Abstract
We explored the genetic basis for the differing immune responses observed in inbred strains of mice to a high-molecular-weight polysaccharide (PS) from Pseudomonas aeruginosa immunotype 1 (IT-1). Previous studies have shown that C3H mice immunized with this antigen produce only immunotype-specific antibody. BALB/c mice immunized with IT-1 PS produce both anti-IT-1 PS antibody and antibody cross-reactive with PS from P. aeruginosa immunotype 2 (IT-2). In the current study, we observed that, in addition, these two strains differ in their ability to respond to low immunizing doses of IT-1 PS. C3H mice generated a protective antibody response after a 1-microgram immunization, whereas BALB/c mice failed to produce protective antibody after receiving 1 microgram of PS. Both strains generated protective levels of antibody after a 50-micrograms immunization. Genetic analysis of these response patterns indicates that the ability to produce cross-reactive antibody and the ability to respond to a 1-microgram immunization are independently inherited traits. In addition, the responsiveness of C3H mice to a 1-microgram immunization with the production of protective levels of antibody is not linked to the mouse major histocompatibility (H-2) complex, to sex-linked genes, or to a single gene outside the H-2 complex.
Similar articles
-
Immunologic basis for mouse protection provided by high-molecular-weight polysaccharide from immunotype 1 Pseudomonas aeruginosa.Rev Infect Dis. 1983 Nov-Dec;5 Suppl 5:S957-62. doi: 10.1093/clinids/5.supplement_5.s957. Rev Infect Dis. 1983. PMID: 6419317
-
Cross-protection by Pseudomonas aeruginosa polysaccharides.Infect Immun. 1982 Dec;38(3):1117-22. doi: 10.1128/iai.38.3.1117-1122.1982. Infect Immun. 1982. PMID: 6185423 Free PMC article.
-
Protective immunity induced in mice by immunization with high-molecular-weight polysaccharide from Pseudomonas aeruginosa.Infect Immun. 1978 Dec;22(3):919-25. doi: 10.1128/iai.22.3.919-925.1978. Infect Immun. 1978. PMID: 103841 Free PMC article.
-
Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain.Vaccine. 2017 Feb 7;35(6):865-872. doi: 10.1016/j.vaccine.2016.12.055. Epub 2017 Jan 10. Vaccine. 2017. PMID: 28087148 Review.
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
Cited by
-
Pseudomonas aeruginosa lipopolysaccharide: evidence that the O side chains and common antigens are on the same molecule.J Bacteriol. 1993 Aug;175(16):5117-28. doi: 10.1128/jb.175.16.5117-5128.1993. J Bacteriol. 1993. PMID: 7688717 Free PMC article.
-
Adoptive transfer of resistance to Pseudomonas aeruginosa infection by splenocytes and bone marrow cells from BALB/c mice immunized by Pseudomonas aeruginosa lectin preparations.Infection. 1989 Nov-Dec;17(6):407-10. doi: 10.1007/BF01645561. Infection. 1989. PMID: 2613334
-
T lymphocyte-mediated protection against Pseudomonas aeruginosa infection in granulocytopenic mice.J Clin Invest. 1986 Aug;78(2):375-80. doi: 10.1172/JCI112587. J Clin Invest. 1986. PMID: 2426306 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical